Miscarriage · pregnant women with a history of one or more UTI before or during pregnancy
It is very uncertain whether nitrofurantoin and close surveillance changes miscarriages compared with close surveillance alone (very low certainty).
1 finding from 1 review
Improvement in pain score (up to nine months after treatment): progesterone versus placebo · women with chronic pelvic pain
Medical treatment probably leads to higher improvement in pain score at end of treatment: progesterone versus… compared with placebo (moderate certainty).
2 findings from 1 review
Weight gain · women with chronic pelvic pain
Medical treatment leads to higher weight gain: progesterone versus placebo compared with placebo (high certainty).
1 finding from 1 review
Bloatedness: progesterone versus placebo · women with chronic pelvic pain
Medical treatment leads to higher bloatedness: progesterone versus placebo compared with placebo (high certainty).
1 finding from 1 review
Peto OR 3.2 [1.37, 7.47]
85 participants
High
Intervention not reported
Improvement in pelvic pain at one year: goserelin versus progestogen · management of chronic pelvic pain
1 finding from 1 review
no estimate extracted
47 participants
Moderate
Adverse events ‐ heterotopic ossification (bone formation) · adults with olecranon fractures
It is very uncertain whether plate fixation changes adverse events ‐ heterotopic ossification (bone formation) compared with tension band wiring (very low certainty).
1 finding from 1 review
Intervention not reported
HIV Transmission at 7 months among those whose HIV diagnostic testing was negative at one month after birth · breastfeeding infants of HIV‐infected mothers
It is very uncertain whether the intervention changes HIV Transmission at 7 months among those whose HIV diagnostic… (very low certainty).
1 finding from 1 review
Intervention not reported
HIV Transmission or Death at 18 months among those whose HIV diagnostic testing was negative at one month after birth · breastfeeding infants of HIV‐infected mothers
It is very uncertain whether the intervention changes HIV Transmission or Death at 18 months among those whose HIV… (very low certainty).
1 finding from 1 review
Intervention not reported
Pyelonephritis · Patients with covert bacteriuria in children
It is very uncertain whether the intervention changes pyelonephritis (very low certainty).
1 finding from 1 review
Intervention not reported
Patient's evaluation of the intervention (including perceptions of safety) · Pregnant women undergoing prenatal serum screening for Down syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Participants' evaluation of the intervention · Patients with long‐term illnesses
1 finding from 1 review
Compliance with treatment ‐ treatment stopped in spite of need ‐ by one year · people with psychosis
SPECIALISED TEAM probably leads to lower compliance with treatment ‐ treatment stopped in spite of need ‐ by… compared with STANDARD CARE (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of subjects who had one or more exacerbations over the study period in adults ( · Adults and children with asthma
The intervention showed no clear difference in number of subjects who had one or more exacerbations over the study… (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of subjects who had one or more exacerbations over the study period in children and adolescents ( · Adults and children with asthma
The intervention showed no clear difference in number of subjects who had one or more exacerbations over the study… (moderate certainty).
1 finding from 1 review
Risk of requiring allogeneic blood transfusion (30 days post‐surgery) · people undergoing definitive fixation of hip, pelvic and long bone fractures
Intravenous tranexamic acid may leads to lower risk of requiring allogeneic blood transfusion (30 days post‐surgery) compared with placebo (low certainty).
1 finding from 1 review
Re‐operation due to bleeding (7 days post‐surgery) ‐ not reported · people undergoing definitive fixation of hip, pelvic and long bone fractures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Myocardial infarction (0 to 30 days) · people undergoing definitive fixation of hip, pelvic and long bone fractures
It is very uncertain whether topical tranexamic acid changes risk of myocardial infarction (30 days post‐surgery) compared with placebo (very low certainty).
1 finding from 1 review
Stroke · people undergoing definitive fixation of hip, pelvic and long bone fractures
It is very uncertain whether topical tranexamic acid changes risk of cerebrovascular accident/stroke (30 days post‐surgery) compared with placebo (very low certainty).
1 finding from 1 review
Deep vein thrombosis · people undergoing definitive fixation of hip, pelvic and long bone fractures
It is very uncertain whether topical tranexamic acid changes risk of deep vein thrombosis (30 days post‐surgery) compared with placebo (very low certainty).
1 finding from 1 review
Risk of suspected serious drug reactions (30 days post‐surgery) · people undergoing definitive fixation of hip, pelvic and long bone fractures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found